Scarborough Advisors’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240 Buy
+27
New +$269 ﹤0.01% 697
2024
Q1
Sell
-27
Closed -$508 647
2023
Q4
$508 Buy
+27
New +$507 ﹤0.01% 660

Other funds holding RMTI

Scarborough Advisors's RMTI Position: Q1 2026 in Review

Scarborough Advisors opened a new position in Rockwell Medical (RMTI) in Q1 2026: 27 shares worth $240. The stake represents ﹤0.01% of the portfolio and ranks #697 among its holdings. This is a return to the name: Scarborough Advisors previously reported a position in RMTI as recently as Q4 2023.

Scarborough Advisors first reported a position in RMTI in Q4 2023 and has held it in 2 quarters since. The position peaked at $508 in Q4 2023. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • Scarborough Advisors held 27 shares of Rockwell Medical worth $240 as of Q1 2026.
  • Rockwell Medical was a new Scarborough Advisors position in Q1 2026.
  • Rockwell Medical made up ﹤0.01% of Scarborough Advisors's portfolio in Q1 2026, its #697 holding.
  • Scarborough Advisors first reported a position in Rockwell Medical in Q4 2023 and has held it in 2 quarters since.
  • Scarborough Advisors's Rockwell Medical position peaked at $508 in Q4 2023.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on Scarborough Advisors's 13F filing for Q1 2026, filed 7 May 2026.